{"hands_on_practices": [{"introduction": "Clinical decision-making often begins with an estimate of how likely a disease is. This exercise demonstrates how to formalize this process using Bayesian reasoning, a cornerstone of evidence-based medicine. By applying a likelihood ratio derived from a patient's symptoms to a known pre-test probability, you will calculate a more precise post-test probability of peptic ulcer disease, transforming clinical suspicion into a quantitative estimate [@problem_id:5193571].", "problem": "A pediatric gastroenterology clinic sees school-aged children with chronic epigastric pain and alarm features. Among similarly symptomatic children evaluated in this setting, the baseline pretest probability of peptic ulcer disease (PUD) is estimated to be $0.10$. A meta-analysis reports that a specific composite symptom pattern (night-time epigastric pain with meal-related exacerbation), when present, has a positive likelihood ratio of $2.0$ for PUD in children. In a particular 11-year-old child from this clinic population, this composite symptom screen is positive.\n\nUsing only fundamental probability principles, specifically Bayes theorem and the definition of the positive likelihood ratio as the ratio of conditional probabilities of a positive finding in disease versus no disease, derive from first principles the child’s post-test probability of PUD after this positive symptom screen. State each step clearly from the core definitions, including any transition from probability to odds and back that you justify from Bayes theorem.\n\nRound your final answer to four significant figures and express it as a decimal probability (do not use a percentage symbol).", "solution": "The problem requires the calculation of a post-test probability of peptic ulcer disease (PUD) given a positive symptom screen. The solution must be derived from first principles, specifically using Bayes' theorem and the definition of a positive likelihood ratio.\n\nLet $D$ be the event that a child has PUD, and let $D^c$ be the complementary event that the child does not have PUD. Let $S+$ be the event that the composite symptom screen is positive.\n\nThe givens from the problem statement are:\n1.  The pretest probability of PUD: $P(D) = 0.10$.\n2.  The positive likelihood ratio for the symptom screen: $LR+ = 2.0$.\n\nFrom the pretest probability, we can deduce the probability of not having PUD:\n$$ P(D^c) = 1 - P(D) = 1 - 0.10 = 0.90 $$\n\nThe objective is to find the post-test probability of PUD given a positive screen, which is denoted as $P(D|S+)$.\n\nWe begin with the statement of Bayes' theorem for the event $D$ given the evidence $S+$:\n$$ P(D|S+) = \\frac{P(S+|D) P(D)}{P(S+)} \\quad (1) $$\n\nThe denominator, $P(S+)$, is the total probability of a positive screen, which can be expanded using the law of total probability:\n$$ P(S+) = P(S+|D)P(D) + P(S+|D^c)P(D^c) \\quad (2) $$\nSubstituting $(2)$ into $(1)$ gives the full form of Bayes' theorem:\n$$ P(D|S+) = \\frac{P(S+|D) P(D)}{P(S+|D)P(D) + P(S+|D^c)P(D^c)} \\quad (3) $$\n\nThe problem provides the positive likelihood ratio, $LR+$, which is defined as the ratio of the probability of a positive test in subjects with the disease to the probability of a positive test in subjects without the disease:\n$$ LR+ = \\frac{P(S+|D)}{P(S+|D^c)} \\quad (4) $$\n\nAs requested, we will now derive the odds form of Bayes' theorem. The odds of an event $A$ are defined as $\\text{Odds}(A) = \\frac{P(A)}{1-P(A)} = \\frac{P(A)}{P(A^c)}$.\n\nThe pretest odds of having PUD are:\n$$ \\text{Pretest Odds} = \\frac{P(D)}{P(D^c)} $$\n\nThe post-test odds of having PUD, given a positive screen $S+$, are:\n$$ \\text{Post-test Odds} = \\frac{P(D|S+)}{P(D^c|S+)} $$\n\nUsing Bayes' theorem for $P(D|S+)$ from equation $(1)$ and its counterpart for $P(D^c|S+)$:\n$$ P(D^c|S+) = \\frac{P(S+|D^c) P(D^c)}{P(S+)} $$\n\nWe form the ratio for the post-test odds:\n$$ \\text{Post-test Odds} = \\frac{P(D|S+)}{P(D^c|S+)} = \\frac{\\frac{P(S+|D) P(D)}{P(S+)}}{\\frac{P(S+|D^c) P(D^c)}{P(S+)}} $$\n\nThe term $P(S+)$ in the denominators cancels, yielding:\n$$ \\text{Post-test Odds} = \\frac{P(S+|D)}{P(S+|D^c)} \\times \\frac{P(D)}{P(D^c)} $$\n\nRecognizing the terms on the right-hand side, we arrive at the odds form of Bayes' theorem:\n$$ \\text{Post-test Odds} = (LR+) \\times (\\text{Pretest Odds}) \\quad (5) $$\nThis derivation from first principles justifies the use of this more direct computational method.\n\nNow, we apply this formula to the given values.\n\nFirst, calculate the pretest odds:\n$$ \\text{Pretest Odds} = \\frac{P(D)}{P(D^c)} = \\frac{0.10}{0.90} = \\frac{1}{9} $$\n\nNext, use equation $(5)$ to find the post-test odds, with the given $LR+ = 2.0$:\n$$ \\text{Post-test Odds} = 2.0 \\times \\frac{1}{9} = \\frac{2}{9} $$\n\nFinally, we convert the post-test odds back to a probability. For any event $A$, the relationship between its probability $P(A)$ and its odds is given by $P(A) = \\frac{\\text{Odds}(A)}{1 + \\text{Odds}(A)}$. Therefore, the post-test probability $P(D|S+)$ is:\n$$ P(D|S+) = \\frac{\\text{Post-test Odds}}{1 + \\text{Post-test Odds}} $$\n$$ P(D|S+) = \\frac{\\frac{2}{9}}{1 + \\frac{2}{9}} = \\frac{\\frac{2}{9}}{\\frac{9}{9} + \\frac{2}{9}} = \\frac{\\frac{2}{9}}{\\frac{11}{9}} = \\frac{2}{11} $$\n\nThe problem requires a decimal answer rounded to four significant figures. We perform the division:\n$$ \\frac{2}{11} \\approx 0.18181818... $$\n\nRounding to four significant figures gives $0.1818$. This is the child's post-test probability of having PUD.", "answer": "$$\\boxed{0.1818}$$", "id": "5193571"}, {"introduction": "Effective treatment of peptic ulcer disease requires not only choosing the right drug but also the right dosing regimen. This practice challenges you to apply pharmacokinetic principles to optimize therapy for a child with persistent symptoms on a standard Proton Pump Inhibitor (PPI) dose. By modeling drug concentration over time, you can quantitatively justify a change in dosing frequency to improve clinical outcomes, a key skill in personalized medicine [@problem_id:5193581].", "problem": "A $24$ kg child with endoscopically confirmed peptic ulcer disease has persistent symptoms despite standard once-daily dosing of the Proton Pump Inhibitor (PPI) omeprazole. You are asked to evaluate whether splitting the total daily dose into twice-daily administrations would improve pharmacodynamic coverage, using a simplified pharmacokinetic model grounded in first-order elimination and a concentration threshold for effective pump inhibition.\n\nAssume a one-compartment model with first-order elimination, oral bioavailability $F = 0.50$, elimination half-life $t_{1/2} = 1$ hour, and volume of distribution $V = 0.30$ L/kg. The total daily dose is set at $1$ mg/kg/day. The pharmacodynamic target is defined as maintaining plasma concentration at or above an effective threshold $C_{\\text{eff}} = 0.10$ mg/L for at least $T_{\\text{target}} = 6$ hours per day, to provide sufficient exposure during meal-stimulated parietal cell activation across morning and evening periods in a child with refractory symptoms. Assume instantaneous absorption at each administration and that exposures from separate doses do not overlap (i.e., doses are separated sufficiently).\n\nLet $N$ be the integer number of equal doses given per day, and let $D_{\\text{daily}}$ be the total daily dose. Using first principles, derive the total daily time above the effective threshold, $T(N)$, in terms of $N$, $F$, $V$, $t_{1/2}$, $C_{\\text{eff}}$, and $D_{\\text{daily}}$, and determine the minimal integer $N \\geq 1$ such that $T(N) \\geq T_{\\text{target}}$. Then compute the per-dose amount $D_{\\text{per}} = D_{\\text{daily}}/N$.\n\nReport your final answer as a two-entry row vector, where the first entry is $D_{\\text{per}}$ in milligrams and the second entry is $N$ (dimensionless). No rounding is required.", "solution": "The concentration of a drug in a one-compartment model following an instantaneous oral dose is described by first-order elimination kinetics:\n$$C(t) = C_0 \\exp(-k_e t)$$\nwhere $C(t)$ is the plasma concentration at time $t$ after the dose, $C_0$ is the initial concentration at $t=0$, and $k_e$ is the first-order elimination rate constant.\n\nThe elimination rate constant $k_e$ is related to the half-life $t_{1/2}$ by:\n$$k_e = \\frac{\\ln(2)}{t_{1/2}}$$\nGiven $t_{1/2} = 1$ hr, the rate constant is $k_e = \\ln(2) \\text{ hr}^{-1}$.\n\nThe problem requires a derivation in terms of the total daily dose $D_{\\text{daily}}$ and total volume of distribution $V$. First, we compute these values for the specified child.\nThe child's mass is $m = 24$ kg.\nThe total daily dose is $D_{\\text{daily}} = D_{\\text{daily,specific}} \\times m = (1 \\text{ mg/kg}) \\times (24 \\text{ kg}) = 24$ mg.\nThe total volume of distribution is $V_{\\text{total}} = V_{\\text{specific}} \\times m = (0.30 \\text{ L/kg}) \\times (24 \\text{ kg}) = 7.2$ L.\n\nIf the total daily dose $D_{\\text{daily}}$ is divided into $N$ equal doses, the amount per dose is $D_{\\text{per}} = \\frac{D_{\\text{daily}}}{N}$.\nThe initial plasma concentration, $C_0$, immediately after one oral dose (assuming instantaneous absorption and distribution) is the bioavailable dose divided by the volume of distribution:\n$$C_0 = \\frac{F \\cdot D_{\\text{per}}}{V_{\\text{total}}} = \\frac{F \\cdot D_{\\text{daily}}}{N \\cdot V_{\\text{total}}}$$\nThe time duration for which the concentration remains at or above the effective threshold $C_{\\text{eff}}$ is found by setting $C(t) = C_{\\text{eff}}$ and solving for $t$. Let this duration be $t_{\\text{duration}}$.\n$$C_{\\text{eff}} = C_0 \\exp(-k_e t_{\\text{duration}})$$\nSolving for $t_{\\text{duration}}$:\n$$t_{\\text{duration}} = \\frac{1}{k_e} \\ln\\left(\\frac{C_0}{C_{\\text{eff}}}\\right)$$\nThis is valid only if $C_0 > C_{\\text{eff}}$. Substituting the expressions for $k_e$ and $C_0$:\n$$t_{\\text{duration}} = \\frac{t_{1/2}}{\\ln(2)} \\ln\\left(\\frac{F \\cdot D_{\\text{daily}}}{N \\cdot V_{\\text{total}} \\cdot C_{\\text{eff}}}\\right)$$\nThe total time per day that the concentration is above $C_{\\text{eff}}$, denoted by $T(N)$, is the duration from a single dose multiplied by the number of doses $N$ (given the no-overlap assumption).\n$$T(N) = N \\cdot t_{\\text{duration}} = N \\frac{t_{1/2}}{\\ln(2)} \\ln\\left(\\frac{F \\cdot D_{\\text{daily}}}{N \\cdot V_{\\text{total}} \\cdot C_{\\text{eff}}}\\right)$$\nThis is the required general expression for $T(N)$.\n\nNext, we must find the minimal integer $N \\geq 1$ such that $T(N) \\geq T_{\\text{target}}$. We substitute the given numerical values into the inequality:\n$D_{\\text{daily}} = 24$ mg, $V_{\\text{total}} = 7.2$ L, $F = 0.50$, $t_{1/2} = 1$ hr, $C_{\\text{eff}} = 0.10$ mg/L, and $T_{\\text{target}} = 6$ hr.\n\n$$N \\frac{1}{\\ln(2)} \\ln\\left(\\frac{0.50 \\cdot 24}{N \\cdot 7.2 \\cdot 0.10}\\right) \\geq 6$$\n$$N \\ln\\left(\\frac{12}{0.72 \\cdot N}\\right) \\geq 6 \\ln(2)$$\nThe term inside the logarithm simplifies: $\\frac{12}{0.72} = \\frac{1200}{72} = \\frac{100}{6} = \\frac{50}{3}$.\nThe inequality becomes:\n$$N \\ln\\left(\\frac{50}{3N}\\right) \\geq \\ln(2^6)$$\n$$N \\ln\\left(\\frac{50}{3N}\\right) \\geq \\ln(64)$$\nWe test integer values for $N$ starting from $N=1$.\n\nFor $N=1$:\nThe left-hand side is $1 \\cdot \\ln\\left(\\frac{50}{3}\\right) = \\ln(16.66...)$. Since $16.66... < 64$, we have $\\ln(16.66...) < \\ln(64)$. Thus, $N=1$ is insufficient.\n\nFor $N=2$:\nThe left-hand side is $2 \\cdot \\ln\\left(\\frac{50}{3 \\cdot 2}\\right) = 2 \\ln\\left(\\frac{25}{3}\\right) = \\ln\\left(\\left(\\frac{25}{3}\\right)^2\\right) = \\ln\\left(\\frac{625}{9}\\right) = \\ln(69.44...)$.\nSince $69.44... > 64$, we have $\\ln(69.44...) > \\ln(64)$. The condition is satisfied for $N=2$.\n\nSince the condition fails for $N=1$ and holds for $N=2$, the minimal integer number of doses per day is $N=2$.\n\nFinally, we compute the per-dose amount $D_{\\text{per}}$ for this regimen.\n$$D_{\\text{per}} = \\frac{D_{\\text{daily}}}{N} = \\frac{24 \\text{ mg}}{2} = 12 \\text{ mg}$$\n\nThe final answer consists of $D_{\\text{per}}$ and $N$.\n$D_{\\text{per}} = 12$ mg.\n$N = 2$.", "answer": "$$\\boxed{\\begin{pmatrix} 12 & 2 \\end{pmatrix}}$$", "id": "5193581"}, {"introduction": "Managing the acute complications of peptic ulcer disease, such as major hemorrhage, demands rapid and precise intervention. This hands-on problem places you in a critical care scenario, requiring you to calculate fluid and blood transfusion volumes for a child in hypovolemic shock. Mastering these calculations, which are based on fundamental physiological principles like blood volume and hemoglobin conservation, is essential for life-saving resuscitation [@problem_id:5193597].", "problem": "An acutely ill child with suspected peptic ulcer disease presents with large-volume hematemesis and melena. The child is hemodynamically unstable with cold extremities and prolonged capillary refill, consistent with hypovolemic shock due to upper gastrointestinal bleeding. The child’s weight is $25$ kg, and the pre-bolus hemoglobin concentration is $6.8$ g/dL. Use the following widely accepted physiological bases:\n- Pediatric estimated blood volume (EBV) is approximately $80$ mL/kg.\n- Initial resuscitation in hypovolemia uses an isotonic crystalloid bolus of $20$ mL/kg.\n- Packed red blood cells (PRBC) have a hemoglobin concentration of approximately $20$ g/dL and are confined to the intravascular space over the acute time frame of resuscitation.\n- Over the short reassessment interval, isotonic crystalloid can be treated as intravascular for the purpose of hemodilution.\n- Mixing is well approximated by conservation of mass for hemoglobin, where hemoglobin mass equals concentration times intravascular volume.\n\nThe plan is to administer an isotonic crystalloid bolus of $20$ mL/kg, reassess, and then transfuse PRBC only if still indicated. To inform decision-making, compute the minimal PRBC volume (in mL) that will achieve a post-transfusion hemoglobin of at least $7.2$ g/dL immediately after the isotonic bolus, subject to the pediatric guideline dosing window of $10$–$15$ mL/kg. Assume complete intravascular mixing and that intravascular volume increases by the full volumes of both crystalloid and PRBC over the relevant time frame. Round your answer to three significant figures and express it in mL.", "solution": "Let $W$ be the child's weight, $H_0$ be the initial hemoglobin concentration, and $V_0$ be the initial estimated blood volume (EBV). The problem provides:\n- $W = 25 \\text{ kg}$\n- $H_0 = 6.8 \\text{ g/dL}$\n- The relationship for EBV is $80 \\text{ mL/kg}$.\n\nFirst, we calculate the child's initial blood volume, $V_0$:\n$$V_0 = 80 \\frac{\\text{mL}}{\\text{kg}} \\times W = 80 \\frac{\\text{mL}}{\\text{kg}} \\times 25 \\text{ kg} = 2000 \\text{ mL}$$\nThe total mass of hemoglobin in the circulation, $M_{Hb,0}$, is the product of its concentration and the volume. To maintain consistent units, we convert the hemoglobin concentration from $\\text{g/dL}$ to $\\text{g/mL}$, knowing that $1 \\text{ dL} = 100 \\text{ mL}$.\n$$H_0 = 6.8 \\frac{\\text{g}}{\\text{dL}} \\times \\frac{1 \\text{ dL}}{100 \\text{ mL}} = 0.068 \\frac{\\text{g}}{\\text{mL}}$$\n$$M_{Hb,0} = H_0 \\times V_0 = 0.068 \\frac{\\text{g}}{\\text{mL}} \\times 2000 \\text{ mL} = 136 \\text{ g}$$\n\nNext, an isotonic crystalloid bolus is administered. Isotonic crystalloids contain no hemoglobin. The volume of the bolus, $V_{crys}$, is given by the formula $20 \\text{ mL/kg}$.\n$$V_{crys} = 20 \\frac{\\text{mL}}{\\text{kg}} \\times W = 20 \\frac{\\text{mL}}{\\text{kg}} \\times 25 \\text{ kg} = 500 \\text{ mL}$$\nAfter this infusion, the total intravascular volume increases to $V_1$. The mass of hemoglobin remains unchanged ($M_{Hb,1} = M_{Hb,0}$), resulting in hemodilution.\n$$V_1 = V_0 + V_{crys} = 2000 \\text{ mL} + 500 \\text{ mL} = 2500 \\text{ mL}$$\nThe new hemoglobin concentration, $H_1$, is:\n$$H_1 = \\frac{M_{Hb,0}}{V_1} = \\frac{136 \\text{ g}}{2500 \\text{ mL}} = 0.0544 \\frac{\\text{g}}{\\text{mL}}$$\nIn conventional units, this is $5.44 \\text{ g/dL}$.\n\nThe next step is to transfuse packed red blood cells (PRBCs) to raise the hemoglobin concentration to a target level, $H_{final} \\ge 7.2 \\text{ g/dL}$. Let $V_{prbc}$ be the volume of PRBCs transfused. The hemoglobin concentration of the PRBCs is given as $H_{prbc} = 20 \\text{ g/dL}$.\n$$H_{prbc} = 20 \\frac{\\text{g}}{\\text{dL}} \\times \\frac{1 \\text{ dL}}{100 \\text{ mL}} = 0.20 \\frac{\\text{g}}{\\text{mL}}$$\nThe mass of hemoglobin added by the transfusion is $M_{Hb,add} = H_{prbc} \\times V_{prbc}$. The total mass of hemoglobin after transfusion, $M_{Hb,final}$, will be the sum of the hemoglobin mass after the crystalloid bolus and the added hemoglobin from the PRBCs.\n$$M_{Hb,final} = M_{Hb,1} + M_{Hb,add} = H_1 \\times V_1 + H_{prbc} \\times V_{prbc}$$\nThe final intravascular volume, $V_{final}$, is the sum of the post-crystalloid volume and the PRBC volume.\n$$V_{final} = V_1 + V_{prbc}$$\nThe final hemoglobin concentration is the ratio of the final hemoglobin mass to the final volume:\n$$H_{final} = \\frac{M_{Hb,final}}{V_{final}} = \\frac{H_1 V_1 + H_{prbc} V_{prbc}}{V_1 + V_{prbc}}$$\nWe need to find the minimal $V_{prbc}$ to achieve $H_{final} = 7.2 \\text{ g/dL}$, which is $0.072 \\text{ g/mL}$. We set $H_{final}$ to this target value and solve for $V_{prbc}$.\n$$0.072 \\frac{\\text{g}}{\\text{mL}} = \\frac{(0.0544 \\frac{\\text{g}}{\\text{mL}})(2500 \\text{ mL}) + (0.20 \\frac{\\text{g}}{\\text{mL}}) V_{prbc}}{2500 \\text{ mL} + V_{prbc}}$$\nRearranging the equation to solve for $V_{prbc}$:\n$$0.072 (2500 + V_{prbc}) = (0.0544)(2500) + 0.20 V_{prbc}$$\n$$180 + 0.072 V_{prbc} = 136 + 0.20 V_{prbc}$$\n$$180 - 136 = (0.20 - 0.072) V_{prbc}$$\n$$44 = 0.128 V_{prbc}$$\n$$V_{prbc} = \\frac{44}{0.128} \\text{ mL} = 343.75 \\text{ mL}$$\nThis is the exact volume of PRBCs required to raise the hemoglobin concentration to precisely $7.2 \\text{ g/dL}$. Since the final hemoglobin concentration is a monotonically increasing function of the transfused volume, any volume less than this will result in a hemoglobin level below the target. Therefore, this is the minimal volume required to meet the target concentration.\n\nFinally, we must verify that this volume is \"subject to the pediatric guideline dosing window of $10$–$15$ mL/kg.\"\nThe dosing window in absolute volume is:\n- Lower limit: $10 \\frac{\\text{mL}}{\\text{kg}} \\times 25 \\text{ kg} = 250 \\text{ mL}$\n- Upper limit: $15 \\frac{\\text{mL}}{\\text{kg}} \\times 25 \\text{ kg} = 375 \\text{ mL}$\nThe guideline window is $[250 \\text{ mL}, 375 \\text{ mL}]$.\nOur calculated minimal volume, $V_{prbc} = 343.75 \\text{ mL}$, falls within this valid dosing range. Thus, the minimal volume that achieves the target hemoglobin level and also complies with the dosing guideline is $343.75 \\text{ mL}$.\n\nThe problem requires the answer to be rounded to three significant figures.\n$$V_{prbc} \\approx 344 \\text{ mL}$$", "answer": "$$\\boxed{344}$$", "id": "5193597"}]}